MK

Mark Ian Kemp

ML Mission Therapeutics Limited: 8 patents #1 of 7Top 15%
Overall (2022): #12,392 of 548,613Top 3%
8
Patents 2022

Issued Patents 2022

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
11472798 Compounds Alison Jones, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock, Andrew Madin 2022-10-18
11414402 Sulfonamide-substituted cyanopyrrolidines with activity as DUB inhibitors Martin Lee Stockley, Andrew Madin, Michael David Woodrow 2022-08-16
11390584 1-cyano-pyrrolidine compounds as USP30 inhibitors Alison Jones, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock 2022-07-19
11370784 Cyano-substituted heterocycles with activity as inhibitors of USP30 Martin Lee Stockley, Andrew Madin 2022-06-28
11352339 1-cyano-pyrrolidine derivatives as DUB inhibitors Alison Jones, Martin Lee Stockley, Michael David Woodrow 2022-06-07
11319287 Cyanopyrrolidines as dub inhibitors for the treatment of cancer Martin Lee Stockley, Alison Jones 2022-05-03
11306096 4,6 dihydropyrrolo [3,4-C] pyrazole-5 (1H)-carbonitrile derivates for treating cancer Alison Jones, Martin Lee Stockley, Michael David Woodrow 2022-04-19
11236092 Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitors Martin Lee Stockley, Michael David Woodrow, Alison Jones 2022-02-01